Prostate Cancer - Results from #27020

The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells - Abstract December 9, 2011

Risk prediction for prostate cancer recurrence through regularized estimation with simultaneous adjustment for nonlinear clinical effects - Abstract December 9, 2011

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life - Abstract December 9, 2011

New ultrasound technologies for the diagnostics of prostate cancer - Abstract December 9, 2011

Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells - Abstract December 9, 2011

Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer - Abstract December 9, 2011

Cause-specific mortality following radical prostatectomy - Abstract December 9, 2011

Cost-effectiveness of Prostate Health Index for prostate cancer detection - Abstract December 8, 2011

Role and expression of FRS2 and FRS3 in prostate cancer - Abstract December 8, 2011

Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance - Abstract December 8, 2011

Surgical therapy for intermediate risk prostate cancer - Abstract December 8, 2011

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores - Abstract December 8, 2011

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer - Abstract December 8, 2011

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer - Abstract December 8, 2011

Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study - Abstract December 8, 2011

Expansion/de-expansion tool to quantify the accuracy of prostate contours - Abstract December 8, 2011

Identification of markers of prostate cancer progression using candidate gene expression - Abstract December 7, 2011

General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations - Abstract December 7, 2011

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies - Abstract December 7, 2011

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer - Abstract December 7, 2011

Page 1352 of 1454